Table 2.
Comparison of Short-Term and Long-Term Effects Between Two Groups
Groups | No (Case) | Intracranial Progression Rate (%) | Median IPFS (Months) | Median OS (Months) |
---|---|---|---|---|
Combination therapy group | 76 | 19.7 | 11.9 | 21.0 |
Target drug group | 72 | 33.3 | 10.2 | 16.7 |
Χ2 value | – | 4.210 | 4.249 | 4.107 |
P value | – | 0.040 | 0.039 | 0.043 |